Positions
Position Company Period
Director Oscient Pharmaceuticals Corp March 19, 2003 -
Independent Trustee Tekla Life Sciences Investors Jan. 1, 2010 -
Independent Trustee Tekla Healthcare Investors June 8, 2010 -
Independent Trustee Tekla World Healthcare Fund Jan. 1, 2015 -
Independent Trustees Tekla Healthcare Opportunities Fund Jan. 1, 2014 -
Lead Independent Director Idera Pharmaceuticals Inc Sept. 1, 2010 - March 10, 2019
Independent Director Madrigal Pharmaceuticals Inc Aug. 1, 2004 - July 22, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-03-01 2021-02-25
B Purchase
1,460 +inf%
17.14
25,024 USD 		1,460 +inf% 17.14 25,024 USD
2021-03-01 2021-02-25
B Purchase
1,196 +inf%
20.85
24,937 USD 		1,196 +inf% 20.85 24,937 USD
2014-07-01 2014-06-30
B Purchase
200 +14.2%
19.75
3,950 USD 		200 +14.2% 19.75 3,950 USD
2013-11-15 2013-11-13
B Purchase
13,333 +57.4%
3.75
49,999 USD 		13,333 +57.4% 3.75 49,999 USD
2012-03-12 2012-03-09
B Purchase
646 +inf%
15.86
10,242 USD 		646 +inf% 15.86 10,242 USD
2012-03-12 2012-03-09
B Purchase
772 +inf%
13.27
10,241 USD 		772 +inf% 13.27 10,241 USD
2004-07-12 2004-07-08
B Purchase
5,974 +115.8%
0.54
3,250 USD 		5,974 +115.8% 0.54 3,250 USD